Mammary tumours in dogs and cats in India: what spaying before the first heat actually prevents, why the cat numbers are worse, and what the surgery costs

Signs of Mammary tumours in dogs and cats

The 8 signs to watch for are listed below. Any one of them is a reason to consult your nearby vet; none of them is a diagnosis.

• A firm lump anywhere along the two rows of nipples, from armpit to groin
• More than one lump, often in the two glands nearest the groin
• A lump that has grown, hardened or become fixed to the skin
• Skin over a gland reddened, broken, weeping or ulcerated
• Discharge from one or more nipples that is not milk
• A whole chain diffusely swollen, hot and painful, with a swollen hind leg
• Coughing or tiring quickly in an animal with a known mammary lump
• Weight loss, poor appetite or lethargy alongside any of the above

Breeds on this site that document this condition

Read the denominator on each card before comparing them, because three different kinds of number are sitting side by side. The Labrador, German Shepherd, Poodle, Yorkshire Terrier and Miniature Schnauzer figures are odds ratios against a national dog population register, which is the only design here that can say a breed is at higher or lower risk than average. The Kerry Blue and English Springer figures are relative risks from insurance claims in a country where bitches are rarely spayed, which measures the same thing in a very different population. The English Cocker figure is a primary-care diagnosis rate with its own control group. The two cat cards are shares of a case series with no population behind them at all, and both are printed with that stated rather than left to look like risks. No Indian study gives a breed breakdown for this disease in either species.

What a mammary tumour is, and which dogs and cats get one

A mammary tumour is a growth in one of the two chains of milk glands that run from the armpit to the groin, and in an entire female dog it is the commonest tumour there is, accounting for 42 percent of all tumours diagnosed in female dogs and 82 percent of tumours of the reproductive organs. Some cancer registries put mammary tumours at 50 to 70 percent of every tumour diagnosed in the intact-bitch subpopulation.

The lifetime figure is worth reading against the human one, because that is the comparison owners make anyway. The Cornell Riney Canine Health Center gives an intact female dog a lifetime mammary cancer risk of 23 to 34 percent, against 12.4 percent for women. Swedish insurance data comes at the same thing from a different angle and lands compatibly: among more than 260,000 insured female dogs with over 1,000,000 dog-years at risk between 1995 and 2006, 11,758 were diagnosed with mammary tumours, an incidence rate of 112 per 10,000 dog-years at risk with a confidence interval of 110 to 114, and 13 percent of all bitches had been diagnosed by the age of ten. A later Swedish cohort of just over 600,000 dogs insured between 2011 and 2016 put the incidence rate at 157 per 10,000 dog-years at risk, with a confidence interval of 154 to 160.

Age is the strongest single predictor and it has a floor. Mammary tumours are rarely diagnosed before age 5, and the average age of affected dogs is 7 to 11 years. The 600,000-dog Swedish cohort puts the median age at first diagnosis at 8.94 years with an interquartile range of 7.43 to 10.5, the Veterinary Society of Surgical Oncology gives a mean of 6 to 10 years and calls the disease rare under 4, and the one Indian series puts its dogs at 5 to 13 years with a mean of 9.1. Those four numbers come from two clinical reference works, a Swedish insurance cohort and an Indian teaching-clinic series, and they agree with each other, which is more than can be said for most of what follows.

The Indian denominator, such as it is

One published Indian epidemiology of this disease exists and it is small. A year of referrals to the Teaching Veterinary Clinical Complex at Sher-e-Kashmir University of Agricultural Sciences and Technology in Jammu found mammary tumours in 12 of 50 tumour cases, which is 24 percent of all tumours and 0.48 percent of all canine cases seen. The fourth and fifth glands, the two nearest the groin, were the most affected, which matches the 65 to 70 percent the international literature attributes to those glands because they carry the greatest volume of mammary tissue.

Set that against the volume of Indian laboratory work on the same disease and the gap is not interest, it is epidemiology. A Europe PMC author-affiliation search run for this page on 27 September 2026 returned 388 records on canine mammary tumours with an Indian affiliation, including biomarker, immunohistochemistry and prognostic work from ICAR-IVRI at Izatnagar and Mukteshwar, Guru Angad Dev Veterinary and Animal Sciences University at Ludhiana and the veterinary university at Mathura, while the abstract search for the same disease terms with India returned 14 records of which one was a genuine Indian canine mammary study. A control for Labrador Retriever with hip dysplasia returned 312 records through the identical route in the same session, so the instrument was working. What India has is a decade of molecular work on tumours that already happened. What it does not have is a population denominator.

In cats the disease is less common and considerably worse. UK primary-care records for 2016 identified 270 mammary tumour cases within a denominator population of 259,869 female cats attending 886 practices, an incidence risk of 104 per 100,000, or 0.104 percent, with a confidence interval of 0.092 to 0.117 percent. Median survival after diagnosis in that population was 18.7 months, and increasing age and purebred status were both associated with increased odds. Most lesions found in the mammary glands of cats are malignant, with aggressive behaviour and an unfavourable prognosis.

Half in dogs, nine in ten in cats, and why the published rates spread so widely

Roughly half of canine mammary tumours are benign and roughly half malignant, while 80 to 90 percent of feline ones are malignant. That single difference changes the urgency, the size of the operation and the conversation, and it is the reason a lump on a cat is never a wait-and-see finding.

Read that table by its denominators and the spread stops being a contradiction. A pathology registry and a referral biopsy service only ever see the lumps somebody thought worth removing and sending away, which is why the Canary Archipelago registry reports 89.2 percent malignant while a specialty reference page counting every mammary lump reports 41 to 53 percent. Neither is wrong. They are not measuring the same population, and a page that prints one of them as the answer is hiding the other.

What survives the spread is the species gap. Every feline figure here sits above every canine figure from a comparable source, and the three cat figures are mutually consistent even though one is a manual estimate, one an owner-facing summary and one a counted biopsy series: the two published ranges are 80 to 90 percent and about 85 to 90 percent, and the measured 83.3 percent falls inside the first of them Srisawat W, Pringproa K, Prachasilchai W.

What that difference does to the operation

Cornell states that it is uncommon to remove the entire mammary chain in a dog, and that in most cases the surgeon removes the tumour itself or the whole affected gland. In cats the opposite holds, precisely because most tumours are malignant. Wide excision is recommended, full-chain mastectomy is associated with a longer disease-free interval than regional mastectomy, and bilateral full-chain mastectomy with a lower risk of local recurrence and metastasis than unilateral, although a bilateral operation done in one session carries higher morbidity than a staged one Veterinary Society of Surgical Oncology. A vet proposing a bigger operation on a cat than on a dog with the same sized lump is following the evidence rather than upselling.

One feline finding should change how urgently an owner acts on a small, soft, undramatic lump. Cats can be clinically normal even with advanced disease, and almost 50 percent of cats with distant metastasis from mammary tumours show no clinical signs of illness at all. A cat that is eating, playing and behaving normally with a pea-sized mammary nodule has told you nothing reassuring.

What spaying before the first heat actually prevents, and why four authorities print it three ways

The three numbers every page repeats are 0.5 percent, 8 percent and 26 percent, and they trace back to one 1969 study by Schneider, Dorn and Taylor in the Journal of the National Cancer Institute. Four current authorities reproduce them, and they do not agree on what the first number is.

Three of those rows describe the same three groups in different words. A bitch spayed before the first heat is the group every row agrees on, and a bitch spayed after her first heat is the same bitch as one spayed before her second. The fourth row is a real disagreement. The 2023 review puts the before-first-heat incidence at 0.05 percent, one tenth of the 0.5 percent that two clinical authorities print Cornell University College of Veterinary…. One of those is a transcription error somewhere in fifty-six years of quotation, and no page opened for this one says which. Both are printed here because a reader deciding on a spay date deserves to know the headline prevention figure is quoted with a tenfold spread.

The systematic review that nobody quotes

In 2012 three epidemiologists at the Royal Veterinary College put the whole question through a Cochrane-style systematic review, and the result is the most important paragraph on this page. Of 11,149 search results, 13 English-language peer-reviewed reports addressed the association between neutering, or age at neutering, and mammary tumours. Nine of the 13 were judged to have a high risk of bias and the remaining four a moderate risk. One study found an association between neutering and reduced risk, two found no evidence of an association, and one reported some protective effect but presented no numbers at all.

The authors' conclusion, in their own words, is that the evidence that neutering reduces the risk of mammary neoplasia, and the evidence that age at neutering has an effect, are judged to be weak and are not a sound basis for firm recommendations. That sentence has been public for fourteen years and appears on none of the ten pages ranking for this condition in India today.

It is not a reason to skip the spay, and it is worth being exact about why. Pyometra was measured in the same Swedish insured population as mammary tumours, at an incidence rate of 199 per 10,000 dog-years against 112 for mammary tumours, with 19 percent of bitches affected by pyometra by the age of ten against 13 percent with a mammary tumour, and 30 percent affected by one or the other. The pyometra page carries that side of the ledger. The mammary argument is the weaker of the two arguments for spaying a bitch, and the honest version of the advice is that the operation is well justified overall while the specific mammary number you were quoted rests on a literature its own systematic review calls weak.

The part where it is supposedly too late

The widely repeated end of the story is that ovariohysterectomy after about two and a half years confers nothing, and the specialty body states it flatly. The MSD Veterinary Manual says that has been questioned, and sets out why. The original retrospective case-control study concluded that spaying after the third oestrus did not decrease mammary tumour risk, but two separate prospective studies, one of them randomised, showed a significantly decreased risk of new tumours in older intact dogs spayed at the same time as the tumour was surgically removed, 36 percent against 64 percent for benign tumours and 31.5 percent against 58.6 percent for malignant ones. The manual reads those results as confirming that cumulative exposure to ovarian hormones after the first few cycles keeps contributing to tumour formation.

That matters more in India than almost anywhere, because the bitch who arrives at an Indian clinic with a mammary lump is typically seven or eight years old and has never been spayed. If she is going under anaesthetic anyway, whether to spay in the same operation is a live question with prospective evidence behind it rather than a closed one, and it is your veterinarian's decision for your animal rather than a rule from a page.

There is a second reason to raise it and a caution attached. The Veterinary Society of Surgical Oncology records that spaying at the time of mastectomy, or within two years of it, significantly increased survival in one dataset, at a median of 755 days against 286 days for dogs spayed more than two years before the mastectomy and 301 days for intact dogs with no concurrent spay, an increase of 45 percent, while other studies found no difference at all, 8.4 months against 8 to 10 months. Cornell calls the same question controversial, with disagreement on both recurrence and survival, and names one clear exception where spaying is recommended, secretory carcinoma, which depends on oestrogen.

Cats: better evidence, a shorter window, and a breed that keeps appearing

A cat spayed before six months of age has a 91 percent lower risk of mammary carcinoma than an intact cat, and one spayed before twelve months an 86 percent lower risk. The protective effect then falls away fast, and the manual states there is no benefit left after two years of age.

Those percentages come from a case-control study run through a university biopsy service, and the underlying counts are worth seeing. Intact cats made up 41 of 150 cases, 27 percent, against 17 of 131 controls, 13 percent, an odds ratio of 2.7 with a confidence interval of 1.4 to 5.3. Spay age was known for 109 cases and 114 controls, and against intact cats the odds ratio was 0.09 for spaying before six months, 0.14 before one year, and 0.89 between thirteen and twenty-four months, which is a statistically non-significant reduction of 11 percent.

The same study reports something the summaries leave out. Ovariohysterectomy performed after two years of age was associated with an increased risk of feline mammary carcinoma compared with staying intact, at an odds ratio of 3.7 with a confidence interval of 1.3 to 12.5. The authors do not read that as spaying causing cancer. They attribute it to the small number of cats spayed after two years, and to the likelihood that cats older than two were spayed because a mammary tumour had been found. Publishing that number without the explanation would be alarming and wrong, which is presumably why most pages publish neither.

Four studies, and a verdict of weak

A 2025 knowledge summary in Veterinary Evidence put the feline question through the same discipline the canine question got in 2012. Four primary studies met the question, three case-control and one retrospective cohort; all four found a protective effect of spaying; and the strength of evidence was graded weak, with a moderate to high risk of bias in every publication.

Read those four rows and the shape of the advice changes slightly. Every study agrees on the direction, none of them is large and clean at the same time, and the one with 23,216 cats behind it reports the smallest effect, an odds ratio of 0.62 rather than the 0.09 everyone quotes. Spay the cat early. Do not tell an owner whose cat was spayed at eighteen months that the science says she has ruined anything.

The Siamese is the breed that keeps turning up and the one to be most careful with. 52 of the 110 cats in the 1981 series were Siamese, which the 2025 appraisal treats as probable sample bias rather than a risk estimate, because it does not reflect the general at-risk population. A Brazilian study of 418 cats states plainly that there are contradictions regarding breed predisposition, while recording that Siamese cats have a higher risk of developing mammary tumours than other breeds with an average age at onset of 9 years. The MSD manual settles for older and purebred cats being over-represented, and UK primary-care records found purebred status associated with increased odds against crossbred cats. If you own a Siamese, a Persian or any pedigree cat in India, the practical reading is to book the spay early rather than to worry.

What you will feel, and the presentation that is not a this-week problem

Almost every mammary tumour is found by an owner who feels a lump, and the first thing to know is that there is usually more than one. Multiple tumours involving more than one gland and both chains occur in 50 to 70 percent of canine cases, and the glands nearest the groin are affected more often than those near the front legs.

A benign mass is usually small, firm and well defined with a clear border, while a malignant one more often grows fast with ragged, ill-defined edges, is fixed to the skin or the tissue beneath it, and may ulcerate or inflame. Ulceration is one of the published poor prognostic factors in its own right, and it carries a second problem in India that no international page mentions. An ulcerated mammary mass is an open wound low on the belly, and through the monsoon and the humid weeks after it an open wound on an Indian dog is a maggot wound waiting to start, which is a reason to cover and treat an ulcerated lump this week rather than next month. Read that as a reason to get a lump looked at sooner rather than as a way to decide at home. Neither clinical examination nor ultrasound separated benign from malignant reliably in the Jammu series, where masses firmly attached to skin and underlying tissue with mixed echo texture turned out to be both.

The clinical signs that change the urgency are listed below.

• A lump that has grown, hardened or attached itself to the skin since you last checked moves up the queue, because size is the prognostic factor with the clearest thresholds and a canine tumour under 3 cm carries a median survival of 22 months against 14 months above it.
• Any mammary lump at all on a cat is a this-week appointment, because 80 to 90 percent of feline mammary tumours are malignant and almost half of cats with distant spread show no sign of being unwell.
• A whole chain diffusely swollen, hot, painful and with a swollen hind leg is the one to act on the same day, because inflammatory mammary carcinoma involves both chains diffusely in 55 percent of cases, causes hind-limb oedema and lameness in 61 percent, and shows regional lymph node metastasis in 96 percent at diagnosis.
• Coughing or tiring quickly alongside a known mammary mass needs a chest radiograph, since the lungs are the commonest distant site and three of the five malignant tumours in the Jammu series had visible lung nodules at diagnosis.
• A mammary mass on a male dog or a male cat is uncommon, and in dogs it is usually malignant.
• Straining to pass faeces in an animal with an inguinal mass can mean the tumour has spread from the inguinal node along the pudendal lymphatics to the sublumbar nodes.

Two ordinary Indian household habits belong in this section, because both are measured risk factors and both are free to change. Obesity raises mammary tumour risk, and specifically the risk is lower in dogs that were thin at 9 to 12 months while being overweight at 12 months is itself a risk factor. Diet pushes the same way. Home-made meals high in beef and pork and low in chicken are associated with increased risk of mammary neoplasia, and the MSD manual lists consumption of a red meat diet alongside obesity, purebred status and small breed size among the risk factors. In a country where most pet dogs eat a home-cooked bowl, that is an unusually actionable finding.

The third habit is not checking. In a Swedish study of 84 privately owned, apparently healthy intact bitches over four years of age, 23 were found at a routine veterinary examination to have mammary masses their owners had not noticed, which is 27.4 percent. The Jamthund page carries that study in full. More than a quarter of ordinary, healthy-looking older bitches were already carrying something, and the only reason anybody knew is that somebody put their hands on the chain.

How it is diagnosed, and what the needle cannot tell you

A fine-needle aspirate is quick, cheap and useful, and in dogs it frequently cannot tell a benign mammary tumour from a malignant one. Histopathology on the removed tissue is what gives the answer, which is why in dogs the diagnosis usually arrives after the surgery rather than before it.

The MSD manual's instruction is to regard all mammary tumours as potentially malignant, and to complete clinical staging before treatment is started because of the risk of spread. The work-up both reference sources describe is a physical and rectal examination, haematology and serum biochemistry, a coagulation profile where a malignant tumour is suspected, thoracic radiographs for lung metastasis, and caudal abdominal radiographs or ultrasonography for the sublumbar lymph nodes Cornell University College of Veterinary….

The clotting check is not padding. At least one haemostatic abnormality was present in 67 percent of dogs with mammary carcinoma, and the frequency rises with histological grade and is higher again with metastasis, extensive necrosis, inflammatory carcinoma, fixed tumours or histological evidence that the tumour has broken through its capsule. The reason the profile is requested is the risk of disseminated intravascular coagulation.

Where the needle does earn its place

Fine-needle aspiration is useful for diagnosing inflammatory carcinoma and for checking a regional lymph node for spread, which is a different question from what the lump itself is. In cats the calculation changes again. Cytology is usually enough to confirm the mass is neoplastic, and given that most feline mammary tumours are malignant and surgery is likely to be recommended anyway, establishing malignancy before the operation matters less.

Ultrasound has one honest use and one clear limit. Benign tumours tend to be spherical to ovoid with regular margins and a homogeneous echo pattern, while malignant ones have irregular margins with heterogeneous internal echogenicity, and in the Jammu series every mammary tumour with a homogeneous echo texture on ultrasound was benign. The limit runs the other way: a heterogeneous mass in that series was benign as often as it was malignant, so a worrying scan is a reason to operate rather than a diagnosis.

One caution about the chest film. Lung lesions smaller than about 0.5 to 1.0 cm may not show on a radiograph, which is the Jammu authors' own explanation for finding nodules in only three of their five malignant cases. A clear chest radiograph is good news and not a guarantee. A cat should have thoracic and abdominal imaging plus aspirates of the local nodes as part of staging, because normal-sized nodes do not exclude metastatic disease and are often not palpable in cats at all.

Treatment, and how much surgery is enough

Surgery is the treatment, and the aim the specialty body names is removal of all neoplastic tissue by the simplest procedure that achieves it. This page names procedures and drug classes and never a dose, because the dose is your veterinarian's decision for the animal in front of them.

The options run from excisional biopsy through local mastectomy, regional mastectomy, unilateral mastectomy and staged or simultaneous bilateral mastectomy. Which one gets chosen has traditionally followed the lymphatic drainage of the glands, glands one to three draining to the axillary and cranial sternal nodes and glands three to five to the superficial inguinal node. That tradition has now been tested and it did not survive.

A 2023 literature review in Acta Veterinaria Scandinavica identified twelve studies covering surgical doses from lumpectomy to radical mastectomy, and found that no study demonstrated a significant association between surgical dose and outcome. The review is careful about what that does and does not prove. Radical mastectomy was the dose analysed in 11 of the 12 articles, which is 92 percent, and dogs treated with simple mastectomy or less were too thinly represented for any conclusion about the least extensive adequate operation. Its recommendation is that the choice of surgical dose should rest on known prognostic factors and the risk of complications rather than on lymphatic drainage.

The clinical side reaches the same place independently. There is no difference in recurrence rate or survival time between simple and radical mastectomy, radical surgery may reduce the risk of new tumours forming in glands left behind, and radical surgery also carries greater morbidity and over-treats both benign and malignant lesions. In dogs with multiple tumours, especially if they are spayed at the same operation, there is no proven benefit in removing normal unaffected glands as a preventive measure.

One clinician's summary states the arithmetic more usefully than the bare malignancy rate does. The rule of thumb is that 50 percent of canine mammary gland tumours are benign and that of the 50 percent that are malignant, half can be cured by surgery alone, which leaves 25 percent of patients at high risk of metastasis and needing something beyond surgery. Read that way, three dogs in four are dealt with by the operation itself, and the work of diagnosis is identifying the fourth.

The counter-argument for taking more rather than less is a second-tumour figure, and it comes with its own caveat attached. A prospective study found that 58 percent of dogs whose malignant tumour was removed by regional mastectomy went on to develop a second tumour in a gland on the same side, which led its researchers to conclude that all malignant tumours should be removed by radical mastectomy. The same summary notes that this would prevent future tumours rather than change the rate of local recurrence, provided a wide excision was achieved, and that every dog in that study was an intact female who was not spayed during it, which may itself have driven the second tumours. Up to 60 percent of dogs that develop a mammary tumour develop more than one, and lumpectomy is generally reserved for tumours that are small, under 0.5 cm, movable and benign.

Two situations take surgery off the table. Metastatic disease and inflammatory carcinoma are both listed as contraindications, because inflammatory carcinoma is usually advanced at diagnosis and recurs. Cornell's version is that with inflammatory mammary carcinoma surgery does not improve survival, so rather than putting the dog through an operation the recommended treatment is radiation therapy together with a non-steroidal anti-inflammatory drug.

Chemotherapy, and what it is and is not for

There is no known effective adjuvant chemotherapy protocol for malignant or metastatic canine mammary tumours. That is the honest headline, and the same source carries one notable exception: a combination of 5-fluorouracil and cyclophosphamide after surgical resection significantly improved survival in dogs with high-risk mammary carcinomas, at a median of 24 months against 6 months for surgery alone. Doxorubicin has better efficacy than the platinum drugs, and hormonal therapy with tamoxifen is limited by adverse effects including vulval swelling, vaginal discharge, incontinence, urinary infection and stump pyometra. In cats, surgery generally gives good local control and the role of adjuvant chemotherapy is not well established.

One Indian clinical study has tested the chemotherapy question locally and it is worth reading with its sample size attached. Eighteen dogs with malignant mammary tumours at the teaching veterinary hospital of Krantisinh Nana Patil College of Veterinary Science at Shirwal in Satara district, Maharashtra, were divided into two groups of nine, one having the tumour excised alone and the other having it excised and then treated with intravenous cyclophosphamide weekly for three consecutive weeks. Seven of the nine chemotherapy dogs, 78 percent, showed complete regression of the tumour after the third dose, and the remaining two recurred after one year; lethargy, moderate alopecia, vomiting, anorexia, anaemia and haematuria were the reported adverse reactions. Nine dogs a group is a small study and its author presents it as retrospective, but it is an Indian one on Indian patients.

That Indian result should be read against an Indian decision that went the other way. The Jammu team used no chemotherapy at all, on the stated grounds that the results have historically been disappointing, and cited work finding no significant difference in recurrence-free interval, time to metastasis or overall survival between surgery alone and surgery with adjuvant chemotherapy. Two Indian teaching hospitals, two defensible positions, both published, and the reader is better served by seeing both than by being handed one.

What the numbers say afterwards, and which ones actually predict

Histological evidence of malignancy does not mean a malignant course, and the Veterinary Society of Surgical Oncology attaches a figure to that: only 4.4 percent of malignant mammary carcinoma cases are fatal. Most dogs with a mammary tumour do not die of it, and the factors that separate the ones who do are measurable before and after the operation. Prognosis in this disease is reported as median survival time by tumour size, clinical stage, histological grade and histological type, and those four between them explain most of the spread.

Two things fall out of that table. The first is that size is the factor an owner can change, because the difference between a 2 cm lump and a 4 cm one is usually the number of weeks between noticing it and doing something about it. The second is that grade, which nobody can change, is the strongest single predictor once the tissue is out, and it only exists at all if the removed tumour was sent for histopathology rather than thrown away.

Histological type carries its own weight. Carcinomas do better than sarcomas, and most dogs with mammary sarcomas die of tumour-related causes within 9 to 12 months. True carcinomas have a metastatic rate of 100 percent against 34 percent for adenocarcinoma arising in a mixed mammary tumour, and recorded mortality runs at 20 percent for lobular adenocarcinoma, 65 percent for ductular adenocarcinoma and 15 percent for other mammary adenocarcinomas. In cats, all cats with lymph node metastasis at the time of surgery in one series developed progressive disease within 8 months.

Follow-up is where the numbers get used. Cornell's recommendation after a malignant tumour is to check for metastasis with chest radiographs or abdominal ultrasound every 3 to 6 months, and to keep monitoring the surgical site and the rest of the chain for recurrence or new tumours. The Jammu team followed their dogs for 3 to 11 months and recorded one recurrence and three deaths, and noted themselves that the follow-up was too short to mean much against published mean survivals of 114 weeks for benign and 70 weeks for malignant tumours.

Breed risk, and the two Indian favourites the reference pages get wrong

Breed risk in this disease is real, unevenly measured, and reported by reference pages in a way the population studies do not support. The two breeds Indian homes own most, the Labrador Retriever and the German Shepherd, are the clearest examples of the gap.

The Veterinary Society of Surgical Oncology's breed predisposition list names Pointers, the Irish Setter, the Brittany Spaniel, the English Springer Spaniel, the Labrador Retriever, the Great Pyrenees, the Samoyed, the Airedale Terrier, the Miniature and Toy Poodle, the Dachshund and the Keeshond. North Carolina State University's oncology service names toy and miniature poodles, spaniels and German Shepherds. Neither attaches an odds ratio or a denominator to any breed on either list.

One study did the arithmetic properly. Rodriguez and colleagues compared 5,240 female dogs with mammary tumours on the Canary Archipelago against the Canarian canine population register, which gives every breed a real denominator instead of a share of biopsy submissions. In that analysis the Labrador Retriever came out at an odds ratio of 0.54 with a 95 percent confidence interval of 0.37 to 0.80 and p equal to 0.0017, significantly lower risk than a crossbred, from 28 cases among 1,831 Labradors. The German Shepherd Dog came out at 1.14 with an interval of 0.84 to 1.54 and p equal to 0.4053, which is no different from a crossbred.

The likely source of the error is a missing denominator. A Mexican biopsy series of 1,917 samples reported that pure breeds accounted for 80 percent of submissions and that the Poodle, Cocker Spaniel and German Shepherd were consistently affected. Counting which breeds turn up most often in a biopsy queue measures which breeds people own and take to referral clinics, not which breeds get the disease. The Yorkshire Terrier shows the same trap from the other side: it supplied 346 of the Canary cases, the largest single count of any breed, at an odds ratio of only 1.92.

Where two large studies flatly disagree

The Bulldog is the cleanest demonstration of why you read the population before the number. The Swedish insurance cohort of just over 600,000 dogs places the English Bulldog among its two lowest-risk breeds at a relative risk of 0.07 with a confidence interval of 0.00 to 0.37. The Canary Archipelago registry places the Bulldog at an odds ratio of 1.95 with an interval of 1.20 to 3.17 and p equal to 0.0071, significantly above crossbreds. Both are large and both are published. One counts insurance claims in a country where bitches are rarely spayed, and the other counts pathology submissions on an archipelago where the neutered share of affected dogs rose from 13.6 to 26.9 percent across the study period Rodriguez J, Santana A, Herraez P.

The Swedish cohort is where the extremes live. The Kerry Blue Terrier carries the highest relative risk of any breed at 4.72 with an interval of 2.58 to 7.92, the English Springer Spaniel is second at 3.32, the lowest are the German Spitz at 0.06 and the English Bulldog at 0.07, and the ages at first diagnosis run from 5.30 years in the Dogue de Bordeaux and 6.42 in the Irish Wolfhound to 10.9 in the Miniature Dachshund and 11.0 in the West Highland White Terrier. Cause-specific mortality was measured too: 486 bitches died of mammary-tumour-related causes at a median age of 9.32 years, and the Large Munsterlander had the highest risk of mammary-tumour-related death at a relative risk of 40.3 with an interval running from 8.28 to 118.4, which is an interval wide enough to say the estimate rests on very few deaths.

Two risk factors from that same cohort are not breed at all and get far less attention than they deserve. Bitches with a history of pseudopregnancy had 2.10 times the odds of a mammary tumour, and bitches with a history of acute mastitis 4.93 times the odds, both with p below 0.001. A 2023 review states the opposite about the first of those, that pseudopregnancy has no relationship with the development of mammary tumours. A 600,000-dog insurance cohort and a narrative review disagree, and both are printed here rather than one being chosen.

One last trap, because it is the kind that gets copied from page to page. The Canary registry lists SCHNAUZER and SCHNAUZER (MINIATURE) as two separate rows with opposite results, an odds ratio of 5.77 with an interval of 2.78 to 12.00 for the first and 0.70 with an interval of 0.29 to 1.70 for the second. If you own a Miniature Schnauzer, the figure that belongs to your dog is the one that is not statistically significant, and any page that gives you 5.77 has read the wrong row.

What treatment costs in India, from three government rate cards

Three Indian government veterinary universities publish what they charge, and between them they price every step of this disease Tamil Nadu Veterinary and Animal Sciences… Bihar Animal Sciences University. No page ranking for this condition in India prints any of it, including the one Indian page in the ranking set.

Every rupee figure here has been divided by 84.38 and by 74 to check it is a native Indian charge and not a converted dollar list. Rs 300 is 3.56 or 4.05 US dollars on those two rates, Rs 500 is 5.93 or 6.76, Rs 1,500 is 17.78 or 20.27 and Rs 2,500 is 29.63 or 33.78. Not one of them lands on a round dollar figure, so these are prices set in rupees.

Read the first two rows together and the prevention argument stops being abstract. The ovariohysterectomy that removes most of the risk is priced at Rs 500 for a pet animal, and the excision of a tumour that has already appeared at Rs 300, plus tax in both cases. Diagnosis is cheap in the same place: the fine-needle aspirate, the cytology and the histopathology that tell you what the lump actually was are Rs 150 each, an ultrasound scan is Rs 250, a plain radiograph is Rs 150 and a complete blood count is Rs 300.

The comparison that makes the point is not between Indian cities but between countries. The same operation on the same disease is priced by North Carolina State University's veterinary hospital at 6,000 to 9,000 US dollars, with chemotherapy at 600 to 800 dollars per treatment across six treatments, definitive radiation at 10,000 to 12,000 dollars and palliative radiation at 2,500 to 6,000 dollars. An Indian owner within reach of a government veterinary college has access to the part of this disease that actually changes the outcome, which is the surgery and the histopathology, at a price measured in hundreds of rupees.

The two rows below the surgery row are the ones India mostly cannot supply, and it is worth knowing where it can. The Tata Memorial Centre's ACTREC campus at Kharghar in Navi Mumbai described itself in a 2015 press item on its own site as the only facility in the country offering chemotherapy and radiotherapy for dogs, treating nearly 150 dogs in the previous year of which nearly 50 had chemotherapy, at a cost of Rs 40,000 to Rs 60,000 depending on treatment cycles. That item is eleven years old and should be read as a floor rather than a current quotation. Since then a private specialist practice, The Cancer Vet, has opened two centres offering chemotherapy, radiation therapy and surgical treatment for pets, one at Chembur in Mumbai and one at Pimpri-Chinchwad in Pune, under a founder the site describes as a board-certified veterinary radiation oncologist, and publishes no prices. For a mammary tumour, those rows matter least of all the rows in the table, because surgery is the treatment and adjuvant chemotherapy has no protocol shown to be effective.

Three caveats before anybody quotes a total from this. These are published charges for named procedures at government teaching hospitals and not a bill, so anaesthesia, consumables, hospitalisation and tax sit on top; Bihar Veterinary College charges Rs 200 per day for a canine or feline inpatient and Rs 200 to register in outpatients. Second, Madras Veterinary College, the teaching hospital of the Tamil Nadu Veterinary and Animal Sciences University, is unusual in that its pharmacy unit runs on an average annual budget of Rs 25,00,000 from which drugs and fluids are procured and dispensed free of cost, which is not the norm. Third, no source opened for this page publishes a rate card for a private clinic in an Indian metro, and none of the three universities lists mastectomy by name, so which fee band a full-chain operation falls into is a question for the hospital rather than for this page.

Prevention and monitoring, on an Indian timetable

Prevention of this disease reduces to one decision made once and one habit repeated monthly. India makes the first harder, because owned bitches are rarely spayed and the national sterilisation programme is aimed at free-roaming dogs rather than pets, and that makes the second more important. The seven steps that follow are ordered by how much each one changes.

1. Fix the spay date with your vet before the first heat rather than after it. The published incidence for a bitch spayed before her first heat is 0.5 percent from the specialty body and 0.05 percent from a 2023 review, against 8 percent one heat later and 26 percent two heats later, and the Royal Veterinary College systematic review judges the evidence behind all of those figures weak Beauvais W, Cardwell JM. The dog sterilisation guide carries the other side of the same decision, including the joint and cancer risks that argue for waiting in a large breed.
2. For a cat, treat six months as the deadline. Spaying before six months carries a 91 percent lower risk of mammary carcinoma, before twelve months 86 percent, and by two years of age the manual says the protective effect is gone. The cat sterilisation guide has the Indian ages, the fees by city and the NGO routes.
3. Refuse the heat-suppression injection and the tablets that do the same job. In the Norwegian Canine Cancer Register, 25 percent of the bitches with mammary tumours had been treated with medroxyprogesterone acetate, and exogenous progestins cause mammary tumour development in cats of both sexes.
4. Keep her lean through the first year. The risk of mammary neoplasia is lower in dogs that were thin at 9 to 12 months, and obesity at 12 months is itself a risk factor.
5. Cut the beef and pork in a home-cooked bowl. Home-made meals high in beef and pork and low in chicken are associated with an increased risk of mammary neoplasia, and the MSD manual names consumption of a red meat diet among the risk factors.
6. Run a hand down both chains once a month from age four. 23 of 84 apparently healthy Swedish bitches over four had masses their owners had never found, and the glands nearest the groin are the ones to palpate hardest, because 65 to 70 percent of mammary neoplasia occurs in glands four and five.
7. If she is already older and intact and a lump has appeared, ask about spaying in the same operation. Two prospective studies, one of them randomised, found significantly fewer new tumours in older intact dogs spayed at the time the tumour was removed, 36 percent against 64 percent for benign tumours and 31.5 percent against 58.6 percent for malignant ones.

There is no screening scheme for this disease, and that is worth stating plainly rather than leaving as a silence. No registry, DNA test, kennel-club scheme or breed health certification exists for mammary tumours in dogs or cats anywhere, which is why this page records no screening scheme at all. The instrument is a pair of hands and a calendar, and there is no test to book instead of using them.

The Indian context that changes the arithmetic is simply the number of entire bitches and queens. The Canary Archipelago study measured what happens when that changes: across eighteen years the neutered proportion of mammary-tumour-affected dogs rose from 13.6 to 26.9 percent while the share of mammary diagnoses among all female-dog tumours fell from 62.7 to 48.9 percent, a negative correlation of R equal to minus 0.84. That is what a population-level shift in spaying looks like in the tumour statistics, measured over two decades in one place. India has not made that shift, and the size of the prize is visible in somebody else's data.

One prevention claim in circulation does not survive checking, and it is on the only Indian page in the ranking set. A Bengaluru animal charity's page states that spaying before the first heat cycle reduces a female dog's lifetime risk of mammary tumours by more than ninety-nine percent in some studies, and names no study for it. Against the published figures, going from 26 percent to 0.5 percent is a reduction of about 98 percent and going from 26 percent to 0.05 percent is about 99.8 percent Vazquez E, Lipovka Y, Cervantes-Arias. An uncited round number that happens to sit between two contested figures is not evidence, and an owner is better served by the two real numbers and the systematic review that calls them weak. The only rupee figure anywhere on that page is a donation appeal in its footer about the monthly cost of keeping a dog at the charity's own sanctuary, which tells an Indian owner nothing about what this disease costs to treat.

Living with it, and deciding how far to go

Most dogs presented with a mammary tumour are systemically healthy, with disease confined to the mammary chains with or without the local lymph nodes, and they stay well after the surgery. That is the usual story and it is a good one, which is the opposite of what the word cancer prepares an owner for.

Declining part of the work-up is a real choice rather than a failure, and the order of value is reasonably clear from the evidence on this page. Removing the lump and sending it for histopathology buys both the treatment and the prognosis in one go, and on the ICAR-IVRI rate card those two together are Rs 300 and Rs 150 plus tax. A chest radiograph at Rs 150 is the next most useful thing, because lung spread is the finding that changes the plan Veterinary Society of Surgical Oncology. A staging computed tomography scan, at Rs 2,500 with a report at Madras Veterinary College, is the one to ask hard questions about if money is finite.

Know what is worth monitoring afterwards. New masses appear in the glands that were left behind, which is simultaneously the argument for radical surgery and the argument against over-treating a benign lesion, and Cornell's follow-up interval after a malignant tumour is imaging every 3 to 6 months. Feel the whole chain at every check rather than only the scar, and in a cat palpate every gland, because multiple tumours are common and all glands should be carefully examined in any cat with a mammary mass or a history of one.

One cross-reference belongs here because it cuts the other way. The strongest argument against spaying early is that it raises the risk of other cancers, and the MSD manual names haemangiosarcoma, osteosarcoma and lymphoma as the consequential ones, noting that unlike mammary tumours those are usually diagnosed at a more advanced stage and most affected dogs die of them despite treatment. Its own resolution is that owners of at-risk breeds are often advised to delay the spay, and that if it is delayed the owner must monitor the dog for mammary tumours by examining her at home, because for this disease early detection and treatment are possible and often associated with favourable outcomes.

That is the whole decision in two sentences, and it is a conversation with your veterinarian rather than a rule from a page. The disease this page describes is the one on that list you can find early with your hands, and the one whose treatment an Indian government hospital prices in hundreds of rupees.